Ingo Ringshausen

The pathological response to DNA damage does not contribute to p53-mediated tumour suppression

Maria A. Christophorou, Ingo Ringshausen, Andrew J. Finch et al. · Nature · 2006 · 383 citations

Life Sciences, Molecular Biology, Oncology +16

Mdm2 is critically and continuously required to suppress lethal p53 activity in vivo

Ingo Ringshausen, Clodagh C. O’Shea, Andrew J. Finch et al. · Cancer Cell · 2006 · 254 citations · Full text

Medicine, Cancer Biology, Oncology +12

Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cδ

Ingo Ringshausen, Folker Schneller, Christian Bogner et al. · Blood · 2002 · 245 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14

Rapamycin-induced G1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin

Thomas Decker, Susanne Hipp, Ingo Ringshausen et al. · Blood · 2002 · 157 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Protein Kinase C-β-Dependent Activation of NF-κB in Stromal Cells Is Indispensable for the Survival of Chronic Lymphocytic Leukemia B Cells In Vivo

Gloria Lutzny, Thomas Köcher, Marc Schmidt‐Supprian et al. · Cancer Cell · 2013 · 149 citations · Full text

Life Sciences, Immunology, Oncology +17